Name: Relias Media
Price range: $

Pharmacology Watch: FDA Heightens Warnings on Chantix

In this issue: Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.

Full March 2008 Issue in PDF

Schistosomiasis and Strongyloidiasis in African Refugees

Refugees resettling to the united states and other developed countries frequently suffer from infectious diseases, and can pose diagnostic or therapeutic dilemmas for health care providers in their new homes.

Pharmacology Watch

Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.

Physicians as Stakeholders in Health Care: PQRI Is An Opportunity to Participate

The Physician Quality Reporting Initiative (PQRI) is a program by the Centers for Medicare and Medicaid Services (CMS) that affects physicians and other health care providers who participate in Medicare. Clinicians in practically all medical specialties can participate in this voluntary reporting initiative and earn a bonus for satisfactory reporting.